Board approves unaudited Q3 FY2025-26 results with notable growth in pharma sales, volumes, EBITDA, and net profit for the nine months ended December 31, 2025.
AI Assistant
Mold-Tek Packaging Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.